New contract with Carna Bioscience

Contract signed with Carna Bioscience

Venn Life Sciences, part of Open Orphan plc announce the signing of a contract with Carna Bioscience (“Carna”) ( for a First In Human Clinical pharmacology trial. The contract is expected to deliver significant revenue for the Company over the next twelve months. Carna is a Japanese company specialising in kinase biology, developing innovative treatments against cancer and immune disorder. Click here to read more